Skip to main content

Advertisement

Log in

What Is New in the Diagnosis and Management of Penile Cancer?

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Penile cancer is more prevalent in India than in the West. Also, the usual stage at the presentation is more advanced in our country. Over the years, there have been various advancements in the diagnosis and management. Evolving concepts like penile preservation to improve quality of life, use of biomarkers to prognosticate, refinement in techniques of sentinel lymph node biopsy, and better evidence for neoadjuvant and adjuvant treatment have been dealt with in this review. This review also highlights the gaps and potential areas of research in management of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Reference

  1. Indian Council of Medical Research (ICMR), National Cancer Registry Programme. Consolidated Report of the Population based cancer registries 1990–1996(2001), New Delhi: ICMR Publication: 114–224.

  2. NCRP-ICMR -Three Year Report of PBCR 2012–2014

  3. Tsen HF et al (2001) Risk factors for PCa: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 12:267

    Article  CAS  PubMed  Google Scholar 

  4. Thuret R et al (2013) A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis. Cancer Causes Control 24:71

    Article  PubMed  Google Scholar 

  5. Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20(12):1645–1654

    Article  PubMed  Google Scholar 

  6. Chaux A, Pfannl R, Rodríguez IM et al (2011) Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol 35:553–562

    Article  PubMed  Google Scholar 

  7. Li ZS, HanH ZZJ, Zhou FJ, Qin ZK, Liu W, Yao K (2014) Modified pathological N2 staging system in prognosis prediction of PCa patients. Chinese Journal of Cancer Prevention and Treatment 21(4):300–303

    Google Scholar 

  8. Kirkham A (2012) MRI of the penis. Br J Radiol 85:S86–S93

    Article  PubMed  PubMed Central  Google Scholar 

  9. Caso JR, Rodriguez AR, Correa J, Spiess PE (2009) Update in the management of PCa. Int Braz J Urol 35(4):406–415

    Article  PubMed  Google Scholar 

  10. Sheng Zhang, Wenfeng Li, Fei Liang (2016) Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in PCa. Oncotarget. May 14.

  11. Backes DM, Kurman RJ, Pimenta JM et al (2009) Systematic review of human papillomavirus prevalence in invasive PCa. Cancer Causes Control 20:449–457

    Article  PubMed  Google Scholar 

  12. Lont AP, Kroon BK, Horenblas S et al (2006) Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119:1078–1081

    Article  CAS  PubMed  Google Scholar 

  13. Weaver BA, Feng Q, Holmes KK et al (2004) Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 189:677–685

    Article  CAS  PubMed  Google Scholar 

  14. Saibishkumar EP, Crook J, Sweet J (2008) Neonatal circumcision and invasive squamous cell carcinoma of the penis: a report of 3 cases and a review of the literature. Can Urol Assoc J 2:39–42

    Article  PubMed  PubMed Central  Google Scholar 

  15. Giuliano AR, Palefsky JM, Goldstone S et al (2011) Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 364:401–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kayes O et al (2007) Molecular and genetic pathways in PCa. Lancet Oncol 8:420

    Article  CAS  PubMed  Google Scholar 

  17. Hegarty PK, Kayes O, Freeman A et al (2006) A prospective study of 100 cases of PCa managed according to European Association of Urology guidelines. BJU Int 98:526–531

    Article  PubMed  Google Scholar 

  18. Vuichoud C, Loughlin KR (2016) The emerging role and promise of biomarkers in PCa. Urol Clin N Am 43:135–143

    Article  Google Scholar 

  19. Zhu Y, Ye DW, Yao XD et al (2008) The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and follow-up of patients with PCa. J Urol 180:2019–2023

    Article  PubMed  Google Scholar 

  20. Stankiewicz E, Ng M, Cuzick J et al (2012) The prognostic value of Ki-67 expression in penile squamous cell carcinoma. J Clin Pathol 65:534–537

    Article  PubMed  Google Scholar 

  21. Gentile V, Vicini P, Giacomelli L et al (2006) Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas. Int J Immunopathol Pharmacol 19:209–215

    CAS  PubMed  Google Scholar 

  22. Ficarra V et al (2010) Prognostic factors in PCa. Urology Aug 76(2 Suppl 1):S66–S73

    Article  Google Scholar 

  23. Cubilla AL (2009) The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol 27:169

    Article  PubMed  Google Scholar 

  24. Rees R.W.et al. (2008) pT2 penile squamous cell carcinomas: cavernosus vs. spongiosus invasion. Eur Urol Suppl 7: 111

  25. Hungerhuber E et al (2006) Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 68:621

    Article  PubMed  Google Scholar 

  26. Li ZS et al (2014) Disease-specific survival after radical lymphadenectomy for PCa: prediction by lymph node count and density. Urol Oncol Aug 32(6):893–900

    Article  Google Scholar 

  27. Li Z-S et al (2016) Development of a new classification method for penile squamous cell carcinoma based on lymph node density and standard pathological risk factors: the ND staging system. J Cancer 7(3):262–267

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chaux A et al (2009) The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol 33:1049

    Article  PubMed  Google Scholar 

  29. Arthur L. Burnett (2016) Penile preserving and reconstructive surgery in the management of PCa; Nature Reviews | Urology Volume 13 May; 249–57

  30. Kroon BK, Horenblas S, Lont A et al (2005) Patients with penile carcinoma benefit from immediate resection of clinically occult LNM. J Urol 173:816–819

    Article  CAS  PubMed  Google Scholar 

  31. Protzel C et al (2009) Lymphadenectomy in the surgical management of PCa. Eur Urol 55:1075–1088

    Article  PubMed  Google Scholar 

  32. Leijte JAP, Kroon BK, Valdés Olmos RA, Nieweg OE, Horenblas S (2007) Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol 52:170–177

    Article  PubMed  Google Scholar 

  33. Neto AS, Tobias-Machado M, Ficarra V et al (2011) Dynamic sentinel node biopsy for inguinal lymph node staging in patients with PCa: a systematic review and cumulative analysis of the literature. Ann Surg Oncol 18:2026–2034

    Article  PubMed  Google Scholar 

  34. Lam W et al (2013) Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution. Eur Urol 63:657–663

    Article  PubMed  Google Scholar 

  35. Dimopoulos P, Christopoulos P, Shilito S et al (2016) Dynamic sentinel lymph node biopsy for PCa: a comparison between 1- and 2-day protocols. BJU Int 117:890–896

    Article  PubMed  Google Scholar 

  36. Carlone M et al (2016) CT-based planning and Monte Carlo dosimetry for penile brachytherapy. Brachytherapy Volume 15(Supplement 1):S155

    Article  Google Scholar 

  37. Pagliaro LC et al (2010) Neoadjuvant paclitaxel, Ifosfamide, and cisplatin chemotherapy for metastatic PCa: a phase II study. J Clin Oncol Aug 20 28(24):3851–3857

    Article  CAS  Google Scholar 

  38. O.W. Hakenberg, E. Compérat, S. Minhas, A. Necchi, C. Protzel, N. Watkin (2016) European Association of Urology Guidelines on Penile cancer

  39. Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32(1):5–15

    CAS  PubMed  Google Scholar 

  40. Noronha V et al (2012) Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk PCa. Urol Ann 4:150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Pond GR et al (2014) Concurrent chemoradiation therapy for men with locally advanced penile squamous cell carcinoma. Clinical Genitourinary Cancer Vol. 12(6):440–446

    Article  Google Scholar 

  42. Patil VM et al (2014) Palliative chemotherapy in carcinoma penis: does platinum and taxane combination holds a promise? Urology Annals Jan - Mar Vol 6(1):18–22

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bakshi Ganesh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahendra, P., Ganesh, B., Gagan, P. et al. What Is New in the Diagnosis and Management of Penile Cancer?. Indian J Surg Oncol 8, 379–384 (2017). https://doi.org/10.1007/s13193-016-0613-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0613-2

Keywords

Navigation